AntiâBAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib
McWilliams, Emily M., Lucas, Christopher R., Chen, Timothy, Harrington, Bonnie K., Wasmuth, Ronni, Campbell, Amanda, Rogers, Kerry A., Cheney, Carolyn M., Mo, Xiaokui, Andritsos, Leslie A., Awan, FarrVolume:
3
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2018025684
Date:
February, 2019
File:
PDF, 1.95 MB
2019